Detalhe da pesquisa
1.
Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A.
Malar J
; 18(1): 13, 2019 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30658710
2.
Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01.
J Infect Dis
; 213(11): 1743-51, 2016 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26908756
3.
A field trial to assess a blood-stage malaria vaccine.
N Engl J Med
; 365(11): 1004-13, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21916638
4.
Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications.
J Infect Dis
; 207(3): 511-9, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23204168
5.
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.
Nat Commun
; 15(1): 4857, 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38849365
6.
Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP).
Malar J
; 12: 185, 2013 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23738590
7.
Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01.
Malar J
; 12: 29, 2013 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23342996
8.
Restricted valency (NPNA)n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum.
NPJ Vaccines
; 7(1): 13, 2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35087099
9.
First-in-human assessment of safety and immunogenicity of low and high doses of Plasmodium falciparum malaria protein 013 (FMP013) administered intramuscularly with ALFQ adjuvant in healthy malaria-naïve adults.
Vaccine
; 40(40): 5781-5790, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055874
10.
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.
Front Cell Infect Microbiol
; 12: 1049065, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36605129
11.
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.
Med
; 2(6): 701-719.e19, 2021 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223402
12.
A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
PLoS One
; 16(9): e0256980, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34495988
13.
The Importance of Exercising Caution When Comparing Results from Malaria Vaccines Administered on the EPI Schedule and on a Seasonal Schedule.
Am J Trop Med Hyg
; 107(6): 1356, 2022 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36410329
14.
A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection.
NPJ Vaccines
; 22017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28804644
15.
Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.
PLoS One
; 12(3): e0173294, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28282396
16.
Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.
PLoS One
; 11(10): e0163026, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27695088
17.
Correction: Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.
PLoS One
; 11(12): e0168952, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27997615
18.
Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate.
Vaccine
; 34(23): 2546-55, 2016 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27087149
19.
A multilateral effort to develop DNA vaccines against falciparum malaria.
Trends Parasitol
; 18(3): 129-35, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11854091
20.
Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes.
PLoS One
; 9(9): e106241, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25211344